- Home
- CLGN vs MTEX Comparison
CLGN vs MTEX Comparison
Compare CLGN & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- MTEX
- Stock Information
- Founded
- CLGN 2004
- MTEX 1993
- Country
- CLGN Israel
- MTEX United States
- Employees
- CLGN N/A
- MTEX N/A
- Industry
- CLGN Industrial Specialties
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- CLGN Health Care
- MTEX Health Care
- Exchange
- CLGN Nasdaq
- MTEX Nasdaq
- Market Cap
- CLGN 19.1M
- MTEX 20.0M
- IPO Year
- CLGN N/A
- MTEX 1999
- Fundamental
- Price
- CLGN $1.37
- MTEX $9.18
- Analyst Decision
- CLGN Strong Buy
- MTEX
- Analyst Count
- CLGN 2
- MTEX 0
- Target Price
- CLGN $11.50
- MTEX N/A
- AVG Volume (30 Days)
- CLGN 127.7K
- MTEX 15.7K
- Earning Date
- CLGN 08-19-2025
- MTEX 08-12-2025
- Dividend Yield
- CLGN N/A
- MTEX N/A
- EPS Growth
- CLGN N/A
- MTEX N/A
- EPS
- CLGN N/A
- MTEX N/A
- Revenue
- CLGN $2,472,000.00
- MTEX $115,036,000.00
- Revenue This Year
- CLGN $2,177.67
- MTEX N/A
- Revenue Next Year
- CLGN $56.52
- MTEX N/A
- P/E Ratio
- CLGN N/A
- MTEX N/A
- Revenue Growth
- CLGN N/A
- MTEX N/A
- 52 Week Low
- CLGN $1.31
- MTEX $6.75
- 52 Week High
- CLGN $5.48
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- CLGN 39.49
- MTEX 46.35
- Support Level
- CLGN $1.35
- MTEX $8.88
- Resistance Level
- CLGN $1.54
- MTEX $10.24
- Average True Range (ATR)
- CLGN 0.14
- MTEX 0.63
- MACD
- CLGN -0.02
- MTEX -0.04
- Stochastic Oscillator
- CLGN 2.88
- MTEX 24.72
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.